Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for Refractory Angina (ARAMIS)
NCT04368819Phase 3Unknown
- Sponsor
- Ministry of Health
- Start
- Mar 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Angina Pectoris (AP) comparing Allopurinol Arm with Placebo Arm (2 arms). Primary endpoint: Total Exercise Time at 16 weeks. Status: unknown.
02
Drugs
allopurinol
03
Conditions
Angina Pectoris (AP)
Beyond the preview
Go deeper on NCT04368819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04368819.